The Supreme Court says Federal Reserve governor Lisa Cook can remain in her job for now, a rebuke to President Donald Trump’s ...
Ongoing research into AI agent framework security identified an exploit chain in AutoGen Studio (AutoGen’s open-source prototyping user interface) that allows untrusted web content rendered by a ...
On June 24, 2026, Microsoft’s Digital Crimes Unit (DCU) facilitated the takedown, suspension, and blocking of domains that ...
Learn essential Nmap commands for network scanning, port discovery, and OS detection. Complete guide with examples and a ...
This week’s cybersecurity recap covers Firefox and Chrome bugs, EDR-killer tools, a TV botnet, an OpenBSD flaw, Android ...
In a rare ruling for a condemned prisoner, the justices would not let Alabama use a contested method of execution. By Adam Liptak Adam Liptak is the chief legal correspondent and host of The Docket.
WHEN ANTHROPIC, an artificial-intelligence lab, debuts on stock markets later this year, it is likely to be one of the biggest initial public offerings in history. That’s because Claude, the company’s ...
Colleges are failing to prepare students for an AI-driven workplace by teaching many of them to treat the technology as cheating, according to Rob Hillard, the CEO of Deloitte's Asia-Pacific branch.
The article mentions how symbolic recursion can destabilize identity and it’s how the true self emerges but it’s kinda vague on the details or the how and I just want to know how much of this is true?
Google is certainly devoting a lot of attention to an agent-driven scientific future. The big scientific announcement at I/O was the new Gemini for Science package, which unites several of the company ...
Shinichi Inoue, VP of Game Development Platform and AI Solutions at Capcom, has revealed during an interview with 4Gamers.net from the Google Cloud Next 2026 in Las Vegas that the Resident Evil ...
With a stock price of $3.32, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the 10 Unrivaled Penny Stocks to Buy Now. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) reported first-quarter ...